How the US drug safety system should be changed

被引：75

作者：

Strom, BL ^{[1
]}

机构：

[1] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 17期

关键词：

D O I：

10.1001/jama.295.17.2072

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2072 / 2075

页数：4

共 19 条

[1] DRUG SAFETY DISCONTINUATIONS IN THE UNITED-KINGDOM, THE UNITED-STATES, AND SPAIN FROM 1974 THROUGH 1993 - A REGULATORY PERSPECTIVE [J].

BAKKE, OM ;

MANOCCHIA, M ;

DEABAJO, F ;

KAITIN, KI ;

LASAGNA, L .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (01) :108-117

[2] The need for a national infrastructure to improve the rational use of therapeutics [J].

Califf, RM .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (04) :319-327

[3]

Gelfand JM, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P337

[4] REYES-SYNDROME AND MEDICATION USE [J].

HALPIN, TJ ;

HOLTZHAUER, FJ ;

CAMPBELL, RJ ;

HALL, LJ ;

CORREAVILLASENOR, A ;

LANESE, R ;

RICE, J ;

HURWITZ, ES .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (06) :687-691

[5] Disproportionality analyses of spontaneous reports [J].

Hennessy, S .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (08) :503-504

[6]

Hennessy S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P281

[7]

HOLMES OW, 1861, WORKS, V9, P185

[8]

Joint Commission on Prescription Drug Use, 1980, FIN REP

[9] Managing the risks of therapeutic products: proceedings of a workshop [J].

Kramer, JM .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (09) :619-628

[10] Timing of new black box warnings and withdrawals for prescription medications [J].

Lasser, KE ;

Allen, PD ;

Woolhandler, SJ ;

Himmelstein, DU ;

Wolfe, SN ;

Bor, DH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (17) :2215-2220

← 1 2 →